Table 2.

Comparison of OMIRROP 2007 and previously published estimates of response and state-attainment.

	Pain	Variables
	Pain	Stiffness	Function	PGA
Definitions of Response
OMIRROP 2007 (hip/knee) estimate	20–29	20–29	20–29	20–29
MCII (absolute) 0–100 nu
MCII75 hip 0–100 nu⁹^*	15.3	NA	7.9	15.2
MCII75 knee 0–100 nu⁹^*	19.9	NA	9.1	18.3
MPCI 0–100 nu⁶^*	9.7	10	9.3	NA
OMERACT-OARSI (high) 0–100 nu⁷^*	≥ 20	NA	≥ 20	NA
OMERACT-OARSI (low) 0–100 nu⁷^*	≥ 10	NA	≥ 10	≥ 10
OMIRROP 2007 (hip/knee) estimate	20–29	20–29	20–29	20–29
MCII (relative) 0–100%
MCII75 hip 0–100%⁹^*	32	NA	21.1	32.6
MCII75 knee 0–100%⁹^*	40.8	NA	26	39
OMERACT-OARSI (high) 0–100%⁷^*	≥ 50	NA	≥ 50	NA
OMERACT-OARSI (low) 0–100%⁷^*	≥ 20	NA	≥ 20	≥ 20
OMIRROP 2007 (hand) estimate	20–29	20–29	20–29	20–29
MCII (absolute) 0–100 nu
MCII75 hand 0–100 nu¹²^**	7.5	9.2	3.5	14.7
OMIRROP 2007 (hand) estimate	20–29	20–29	20–29	20–29
MCII (relative) 0–100%
MCII75 hand 0–100%¹²^**	15.1	14.2	8.0	19.7
Definitions of State-attainment
OMIRROP 2007 (hip/knee) estimate	20–29	30–39	30–39	30–39
PASS (absolute) 0–100 nu
PASS75 (hip) 0–100 nu¹⁴^*	35	NA	34.4	34.6
PASS75 (knee) 0–100 nu¹⁴^*	32.3	NA	31	32
BLISS (knee) 0–100 nu¹⁶^*	≤ 10	NA	NA	NA
OMIRROP 2007 (hand) estimate	30–39	30–39	20–29	30–39
PASS (absolute) 0–100 nu
PASS75 (hand) 0–100 nu¹⁷^**	41	37.8	44.8	41.6
BLISS (hand) 0–100 nu¹³^**	≤ 10	NA	NA	NA

↵* Published as a full report.
↵** Published as an abstract. OMIRROP: Osteoarthritis Measurement in Routine Rheumatology Outpatient Practice; MCII: Minimum Clinically Important Improvement; MPCI: Minimum Perceptible Clinical Improvement; OMERACT-OARSI: Outcome Measures in Rheumatoid Arthritis Clinical Trials–Osteoarthritis Research Society International; PASS: Patient Acceptable Symptom State; BLISS: Bellamy et al Low Intensity Symptom State-attainment Index; nu: numeric units; PGA: patient global assessment; NA: not available.